1 |
Adams JS, Modlin RL, Diz MM, et al (1989). Potentiation of the macrophage 25-hydroxyvitamin D-1-hydroxylation reaction by human tuberculous pleural effusion fluid. J Clin Endocrinol Metab, 69, 457-60.
DOI
|
2 |
Ahmed L, Ip H, Rao D, et al (2014). Talc pleurodesis through indwelling pleural catheters for malignant pleural effusions: retrospective case series of a novel clinical pathway. Chest, 146, 190-4.
|
3 |
Fysh ET, Bielsa S, Budgeon CA, et al (2014). Predictors of Clinical Use of Pleurodesis and/or Indwelling Pleural Catheter Therapy for Malignant Pleural Effusion. Chest.
|
4 |
Gaafar R, Abdel Rahman AR, Aboulkasem F, et al (2014). Mistletoe preparation (Viscum Fraxini-2) as palliative treatment for malignant pleural effusion: a feasibility study with comparison to bleomycin. Ecancermedicalscience, 8, 424.
|
5 |
Morabito A, Gebbia V, Di Maio M, et al (2013). Randomized phase III trial of gemcitabine and cisplatin vs. gemcitabine alone in patients with advanced non-small cell lung cancer and a performance status of 2: the CAPPA-2 study. Lung Cancer, 81, 77-83.
DOI
|
6 |
Rafiei R, Yazdani B, Ranjbar SM, et al (2014). Long-term results of pleurodesis in malignant pleural effusions: Doxycycline vs Bleomycin. Adv Biomed Res, 3, 149.
DOI
|
7 |
Sahn SA (1997). Pleural diseases related to metastatic malignancies. Eur Respir J, 10, 1907-13.
DOI
|
8 |
Shao H, Hong G, Luo X (2014). Evaluation of sodium cantharidinate/vitamin B6 in the treatment of primary liver cancer. J Cancer Res Ther, 10, 75-8.
DOI
|
9 |
Strizzi L, Catalano A, Vianale G, et al (2001). Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma. J Pathol, 193, 468-75.
DOI
|
10 |
Thomas R, Francis R, Davies HE, et al (2014). Interventional therapies for malignant pleural effusions: the present and the future. Respirol, 19, 809-22.
DOI
|
11 |
Wang B, Cui J (2014). Treatment of mid-late stage NSCLC using sodium cantharidinate/vitamin B6/GP regimen in clinic. J Cancer Res Ther, 10, 79-81.
|
12 |
Wang XF, Wu YH, Jiao J, et al (2013). Diagnostic value of superoxide dismutase in tuberculous and malignant pleural effusions. Asian Pac J Cancer Prev, 14, 821-4.
DOI
|
13 |
Yildiz PB, Yazar EE, Gorgun D, et al (2011). Predictive role of adenosine deaminase for differential diagnosis of tuberculosis and malignant pleural effusion in Turkey. Asian Pac J Cancer Prev, 12, 419-23.
|
14 |
Zhang Y, Yu LK, Lu GJ, et al (2014). Prognostic values of VEGF and endostatin with malignant pleural effusions in patients with lung cancer. Asian Pac J Cancer Prev, 15, 8435-40.
DOI
|
15 |
Zhao WY, Chen DY, Chen JH, et al (2014). Effects of intracavitary administration of Endostar combined with cisplatin in malignant pleural effusion and ascites. Cell Biochem Biophys, 70, 623-8.
DOI
|